Data + Perspectives: The Current and Future Role of Immune
Checkpoint Inhibitors and Other Novel Therapies in the Management
of Gynecologic Cancers — Interview with Dr Birrer on the following
topics:
Diagnosis and management of endometrial cancer with POLE
mutation (00:00)
Mechanism of action and tolerability of
pembrolizumab/lenvatinib in patients with endometrial cancer
(3:39)
Clinical outcomes with and optimal integration of ICIs for
ovarian cancer and cervical cancer (14:53)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.